☆ 4.6 Review

Neuroimaging to monitor worsening of multiple sclerosis: advances supported by the grant for multiple sclerosis innovation

FRONTIERS IN NEUROLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

How patients with multiple sclerosis acquire disability

Fred D. Lublin et al.

Summary: Patients with multiple sclerosis can acquire disability through either relapse-associated worsening or progression independent of relapses. This study found that early progression begins in all phenotypes of the disease, becoming the primary driver of disability accumulation in the progressive phase. Treatments with disease-modifying therapies significantly delay disability accumulation, with the greatest impact seen in patients in the earliest stages of multiple sclerosis.

BRAIN (2022)

Add to Collection

Article Clinical Neurology

Productivity loss among people with early multiple sclerosis: A Canadian study

Elisabet Rodriguez Llorian et al.

Summary: This study analyzed work productivity loss and costs among employed people with multiple sclerosis (pwMS) in Canada, as well as its association with clinical, sociodemographic, and work-related factors. The results showed that pwMS experienced significant productivity loss and costs, with fatigue being a key factor contributing to the loss.

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Article Clinical Neurology

Direction and magnitude of displacement differ between slowly expanding and non-expanding multiple sclerosis lesions as compared to small vessel disease

Tatum M. Moog et al.

Summary: Distinguishing between multiple sclerosis (MS) and small vessel disease (SVD) lesions can be achieved by identifying the movement patterns of enlarging and contracting foci. MS lesions move towards the cortex when their volume increases, while they move towards the center when their volume decreases. Compared to SVD, MS lesions have greater distances between centroids.

JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis

Olavi Misin et al.

Summary: Translocator protein (TSPO) radioligand binding in gray matter (GM) predicts later disability progression in multiple sclerosis (MS) according to this study. The research findings suggest that patients with a higher TSPO binding in the thalamus are more likely to experience subsequent worsening of disability. The thalamic distribution volume ratio (DVR) was the only imaging variable that remained a significant predictor of disability progression. The final logistic regression model achieved 52.9% sensitivity and 93.9% specificity, with an area under the curve (AUC) value of 0.82.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)

Add to Collection

Review Clinical Neurology

Microglia in multiple sclerosis - pathogenesis and imaging

Laura Airas et al.

Summary: This review examines the activation of microglia in multiple sclerosis (MS) and its detection using positron emission tomography (PET). The study finds that persistent activation of microglia contributes to injury in MS, and PET imaging with TSPO ligands offers a means to detect and monitor microglia activation in individuals with MS. These findings highlight the importance of developing CNS penetrant inhibitors and using PET imaging as a tool for monitoring treatment responses in MS.

CURRENT OPINION IN NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Mitochondrial measures in neuronally enriched extracellular vesicles predict brain and retinal atrophy in multiple sclerosis

Dimitrios C. Ladakis et al.

Summary: This study aimed to evaluate the relationship between levels of mitochondrial complex IV and V activity and brain and retinal atrophy in multiple sclerosis (MS). The results showed that higher mitochondrial complex IV activity and lower mitochondrial complex V activity levels were significantly associated with faster whole-brain volume atrophy. The findings suggest that mitochondrial measures in circulating extracellular vesicles could serve as potential biomarkers of disease progression in MS.

MULTIPLE SCLEROSIS JOURNAL (2022)

Add to Collection

Editorial Material Clinical Neurology

Multiple sclerosis is one disease

Gavin Giovannoni et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)

Add to Collection

Review Medical Informatics

The role of machine learning in developing non-magnetic resonance imaging based biomarkers for multiple sclerosis: a systematic review

Md Zakir Hossain et al.

Summary: The use of machine learning (ML) can help assess the severity of multiple sclerosis (MS), but its application in developing decision aids for clinicians and analyzing treatment responses requires appropriate data resources and shared experimental protocols.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2022)

Add to Collection

Review Clinical Neurology

Bruton's Tyrosine Kinase Inhibition in Multiple Sclerosis

Raphael Schneider et al.

Summary: Multiple sclerosis is an inflammatory disease of the central nervous system with limited treatment options. New experimental therapy, such as Bruton's Tyrosine Kinase Inhibitors (BTKIs), shows potential in targeting the immunopathology of the central nervous system. There are ongoing clinical trials to evaluate the efficacy and safety of BTKIs in different forms of multiple sclerosis.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2022)

Add to Collection

Article Clinical Neurology

Dorsal medulla surface texture: Differentiating neuromyelitis optica spectrum disorder from multiple sclerosis

Darin T. Okuda et al.

Summary: This study found that the surface texture differences within selective regions of vulnerability in the dorsal medulla can differentiate neuromyelitis optica spectrum disorder (NMOSD) from multiple sclerosis (MS).

JOURNAL OF NEUROIMAGING (2022)

Add to Collection

Review Health Care Sciences & Services

A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple Sclerosis

Nadia Barizzone et al.

Summary: This study conducted a scoping review on prognostic biomarkers in MS, identifying a few biomarkers that can predict the risk of conversion from CIS to clinically definite MS, while others require further research to determine their reliability. Serum and CSF levels of neurofilaments are considered promising biomarkers for MS prognosis.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Article Neuroimaging

Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study

Henning H. Rise et al.

Summary: Connectivity-based approaches can be more sensitive in detecting axonal damage in patients with multiple sclerosis. This study used individual brain disconnectome mapping to investigate the associations between imaging-based brain network aberrations and levels of serum neurofilament light chain (NfL) as a biomarker for neuroaxonal injury.

NEUROIMAGE-CLINICAL (2022)

Add to Collection

Article Clinical Neurology

Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET

Marjo Nylund et al.

Summary: The study used 18 kDa translocator protein-PET imaging to phenotype chronic lesions in multiple sclerosis, finding that secondary progressive patients had a higher proportion of rim-active lesions compared to relapsing-remitting patients, and these lesions were correlated with disability.

BRAIN COMMUNICATIONS (2022)

Add to Collection

Review Clinical Neurology

Smouldering multiple sclerosis: the 'real MS'

Gavin Giovannoni et al.

Summary: This article challenges the view that multiple sclerosis is purely an inflammatory disease and proposes a more comprehensive pathological process. It also emphasizes the importance of considering systemic disease processes in the management of multiple sclerosis.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2022)

Add to Collection

Article Health Care Sciences & Services

Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis

Ann-Marie Mallon et al.

Summary: Novartis and the University of Oxford's BDI have formed a research alliance to enhance healthcare and drug development through advanced statistical machine learning technology and an innovative IT platform. By analyzing anonymized data from various sources, they aim to identify novel patterns with clinical relevance to predict patient disease activity and progression.

BMC MEDICAL RESEARCH METHODOLOGY (2021)

Add to Collection

Article Clinical Neurology

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design

Jiwon Oh et al.

Summary: Background: Neurological disability progression is common in people with MS, with no effective treatments available to modify clinical progression. The CanProCo study in Canada aims to identify factors associated with disease progression through a multidimensional approach, with a focus on characterizing determinants to develop effective interventions.

BMC NEUROLOGY (2021)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Cellular sources of TSPO expression in healthy and diseased brain

Erik Nutma et al.

Summary: TSPO, located in the outer mitochondrial membrane, is considered an in vivo marker of neuroinflammation as measured with PET. Changes in TSPO expression are observed in neurodegenerative, neuroinflammatory, and neuropsychiatric diseases, but further studies are needed to fully understand its cellular underpinnings and functional significance.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Article Clinical Neurology

Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposal

Fernando Dangond et al.

Summary: Members of the International Progressive MS Alliance discuss the importance of experimental medicine trials for developing treatments for progressive multiple sclerosis and announce their funding programme for such trials. The Alliance aims to expedite the development of effective therapies for progressive MS through new initiatives that foster innovative thinking and concrete advancements. They are seeking public and academic feedback to shape the programme and future strategies.

NATURE REVIEWS NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Multi-layer analysis of quantitative 7 T magnetic resonance imaging in the cortex of multiple sclerosis patients reveals pathology associated with disability

Alfonso Lema Dopico et al.

Summary: The study evaluates the sensitivity of quantitative magnetic resonance imaging measurements on cortical layers as biomarkers of grey matter pathology in MS patients. The research reveals specific relationships between cortical layers and disability in MS, which are often hidden when analyzing the full cortex.

MULTIPLE SCLEROSIS JOURNAL (2021)

Add to Collection

Editorial Material Clinical Neurology

Seeing the Finish Line Can Baseline OCT Values Predict Long-term Disability and Therapeutic Management in Multiple Sclerosis?

Pablo Villoslada et al.

NEUROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Corneal confocal microscopy demonstrates axonal loss in different courses of multiple sclerosis

Ioannis N. Petropoulos et al.

Summary: Axonal loss is the main determinant of disease progression in multiple sclerosis, and corneal confocal microscopy was found to be useful in detecting corneal axonal loss in different courses of MS. The study confirmed significant corneal axonal loss in MS patients, including those with clinically isolated syndrome, using two independent segmentation methods. The corneal nerve parameters were comparably reduced in different courses of MS, with excellent reproducibility between the algorithms.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Clinical Neurology

Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration

Ynn van Olst et al.

Summary: The study identified two distinct microglial populations, MS1 and MS2, in the cortex of progressive MS patients, which differentially associate with neurodegeneration. Results suggest that microglia may initially protect neurons from meningeal inflammation-induced cell death by regulating synaptic location and phagocytosis, but over time, this protective property may be lost.

ACTA NEUROPATHOLOGICA (2021)

Add to Collection

Review Clinical Neurology

Early Aggressive Treatment Approaches for Multiple Sclerosis

Alexandra Simpson et al.

Summary: This review provides a comprehensive analysis of current high-efficacy disease-modifying therapies for the treatment of multiple sclerosis (MS). It discusses both approved and emerging therapies for patients with different forms of MS, as well as treatment considerations in pediatric and pregnant populations. The review also covers the treatment paradigms of escalation and early aggressive approaches, with a focus on ongoing clinical trials comparing these strategies.

CURRENT TREATMENT OPTIONS IN NEUROLOGY (2021)

Add to Collection

Article Health Care Sciences & Services

Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis

Elisabet Lopez-Soley et al.

Summary: This study found that cognition in MS deteriorates 5 years after disease onset, declining steadily over the next 25 years and more markedly affecting verbal memory. Baseline measures such as education, disease severity, lesion burden, and volume of limbic structures are predictive of future CI and may help identify at-risk patients.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping

Seongjin Choi et al.

Summary: This study investigated gadolinium-induced changes in T1 relaxation time in non-enhancing MS lesions using 7T MRI, finding that Delta T1 in NELs correlated with disability and was greater and more variable in progressive forms of MS. The measurement of Delta T1 may be a potential biomarker for disease severity and treatment effect in MS.

PLOS ONE (2021)

Add to Collection

Article Ophthalmology

Abnormal Dynamic Pupillometry Relates to Neurologic Disability and Retinal Axonal Loss in Patients With Multiple Sclerosis

Gulfidan Bitirgen et al.

Summary: This study found that dynamic pupillometry revealed significant alterations in pupillary light reflex responses associated with neurologic disability and retinal axonal loss in patients with MS. Initial pupil diameter and contraction amplitude were lower in MS patients compared to healthy controls, and were correlated with EDSS score and RNFL thickness. No significant differences were found in pupillary responses between eyes with and without a history of optic neuritis, and between the eyes of patients with previous unilateral ON.

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)

Add to Collection

Article Ophthalmology

Corneal Immune Cells Are Increased in Patients With Multiple Sclerosis

Adnan Khan et al.

Summary: This study compared corneal immune cell density and near-nerve distance in different subtypes of patients with multiple sclerosis using corneal confocal microscopy (CCM). The results showed increased immature immune cell density and near-nerve distance in MS patients, suggesting CCM may serve as an imaging biomarker for assessing neuroimmune alterations in MS.

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)

Add to Collection

Article

Predicting Long-term Disability in Multiple Sclerosis: A Narrative Review of Current Evidence and Future Directions

Bianca Weinstock-Guttman et al.

International Journal of MS Care (2021)

Add to Collection

Review Immunology

Towards PET imaging of the dynamic phenotypes of microglia

Wissam Beaino et al.

Summary: There is increasing evidence showing the heterogeneity of microglia activation in neuroinflammatory and neurodegenerative diseases. Pro-inflammatory microglia are believed to be detrimental while anti-inflammatory microglia may aid in damage repair. PET imaging shows potential for non-invasive quantification of neuroinflammation and discrimination between microglia phenotypes, but obstacles remain in targeting specific markers for selective imaging.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

Add to Collection

Article Neurosciences

Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain

Erik Nutma et al.

Summary: The expression of TSPO in the human central nervous system may reflect cell density rather than activation status of microglia/macrophages. This has implications for interpreting TSPO PET signals in MS and other CNS diseases, highlighting the limitations of extrapolating TSPO biology from rodents to humans.

GLIA (2021)

Add to Collection

Review Clinical Neurology

Positron emission tomography in multiple sclerosis - straight to the target

Benedetta Bodini et al.

Summary: With significant progress in treating relapsing-remitting MS, the main challenge now is developing treatments to prevent or delay progressive forms of the disease. A deep understanding of the mechanisms behind neuro-axonal degeneration is crucial for developing therapies for progressive MS. PET imaging plays a key role in providing insights into the mechanisms of irreversible neuro-axonal damage in MS.

NATURE REVIEWS NEUROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients

Elisabeth Solana et al.

Summary: In multiple sclerosis, the diffusion rate and volume changes of gray matter show differential spatial predominance in different brain regions as the disease progresses. Furthermore, microstructural integrity loss and atrophy at different stages are associated with white matter lesion load and physical and cognitive disability.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Ophthalmology

In Vivo Molecular Changes in the Retina of Patients With Multiple Sclerosis

Salut Alba-Arbalat et al.

Summary: Raman spectroscopy was used to quantify molecular changes in the retina of multiple sclerosis (MS) patients. Significant metabolic alterations were observed in the retina of MS patients, with changes in specific molecules associated with axonal degeneration and neuroinflammation. These dynamic changes over time suggest progressive neurodegeneration in MS patients.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2021)

Add to Collection

Article Neuroimaging

Cortical fractal dimension predicts disability worsening in Multiple Sclerosis patients

Eloy Roura et al.

Summary: Fractal geometry analysis of brain MRI revealed significant longitudinal changes and identified lower cortical fractal dimension as a predictor for disability accumulation in Multiple Sclerosis patients over a 5-year period.

NEUROIMAGE-CLINICAL (2021)

Add to Collection

Article Clinical Neurology

No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis

Mehrnaz Ighani et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study

Marloes H. J. Hagens et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Add to Collection

Article Medicine, Research & Experimental

Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: The DELIVER-MS study protocol

Daniel Ontaneda et al.

CONTEMPORARY CLINICAL TRIALS (2020)

Add to Collection

Review Pharmacology & Pharmacy

New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis

Pablo Villoslada et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)

Add to Collection

Article Clinical Neurology

BOLD signal within and around white matter lesions distinguishes multiple sclerosis and non-specific white matter disease: a three-dimensional approach

Dinesh K. Sivakolundu et al.

JOURNAL OF NEUROLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Treatment of Multiple Sclerosis: A Review

Stephen L. Hauser et al.

AMERICAN JOURNAL OF MEDICINE (2020)

Add to Collection

Article Clinical Neurology

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

Ludwig Kappos et al.

JAMA NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)

Ellen M. Mowry et al.

FRONTIERS IN NEUROLOGY (2020)

Add to Collection

Article Clinical Neurology

7T MPFLAIR versus MP2RAGE for Quantifying Lesion Volume in Multiple Sclerosis

Margaret Spini et al.

JOURNAL OF NEUROIMAGING (2020)

Add to Collection

Article Clinical Neurology

Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis

Marcus Sucksdorff et al.

BRAIN (2020)

Add to Collection

Article Multidisciplinary Sciences

Retinal and brain damage during multiple sclerosis course: inflammatory activity is a key factor in the first 5 years

Irene Pulido-Valdeolivas et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Immunology

PET imaging of P2X7R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [11C]SMW139

Wissam Beaino et al.

JOURNAL OF NEUROINFLAMMATION (2020)

Add to Collection

Article Clinical Neurology

Sex-specific differences in rim appearance of multiple sclerosis lesions on quantitative susceptibility mapping

B. Tolaymat et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Add to Collection

Article Ophthalmology

Progressive Loss of Corneal and Retinal Nerve Fibers in Patients With Multiple Sclerosis: A 2-Year Follow-up Study

Gulfidan Bitirgen et al.

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Utility of shape evolution and displacement in the classification of chronic multiple sclerosis lesions

Darin T. Okuda et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Clinical Neurology

Silent progression in disease activity-free relapsing multiple sclerosis

Bruce A. C. Cree et al.

ANNALS OF NEUROLOGY (2019)

Add to Collection

Review Clinical Neurology

The MSBase registry: Informing clinical practice

Tomas Kalincik et al.

MULTIPLE SCLEROSIS JOURNAL (2019)

Add to Collection

Article Clinical Neurology

Three-Dimensional Lesion Phenotyping and Physiologic Characterization Inform Remyelination Ability in Multiple Sclerosis

Dinesh K. Sivakolundu et al.

JOURNAL OF NEUROIMAGING (2019)

Add to Collection

Article Clinical Neurology

Natalizumab treatment reduces microglial activation in the white matter of the MS brain

Marcus Sucksdorff et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)

Add to Collection

Article Clinical Neurology

Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis

S. N. Jonas et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2018)

Add to Collection

Article Clinical Neurology

Three-Dimensional Shape and Surface Features Distinguish Multiple Sclerosis Lesions from Nonspecific White Matter Disease

Braeden D. Newton et al.

JOURNAL OF NEUROIMAGING (2017)

Add to Collection

Article Clinical Neurology

Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume

Daniel M. Harrison et al.

JOURNAL OF NEUROIMAGING (2017)

Add to Collection

Article Immunology

Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis

Wissam Beaino et al.

JOURNAL OF NEUROINFLAMMATION (2017)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis

Marcus Sucksdorff et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Add to Collection

Article Clinical Neurology

Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation

Ulrike W. Kaunzner et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)

Add to Collection

Article Ophthalmology

Corneal Confocal Microscopy: An Imaging Endpoint for Axonal Degeneration in Multiple Sclerosis

Ioannis N. Petropoulos et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)

Add to Collection

Review Clinical Neurology

Optimizing treatment success in multiple sclerosis

Tjalf Ziemssen et al.

JOURNAL OF NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

The 18 kDa Translocator Protein, Microglia and Neuroinflammation

Guo-Jun Liu et al.

BRAIN PATHOLOGY (2014)

Add to Collection

Article Endocrinology & Metabolism

Kinetic modeling without accounting for the vascular component impairs the quantification of [11C]PBR28 brain PET data

Gaia Rizzo et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)

Add to Collection

Article Neurosciences

Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging

Sonia Lavisse et al.

JOURNAL OF NEUROSCIENCE (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.